Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 3221-3225

  Hour, T C ^a   Chen, J ^a   Huang, C Y ^a   Guan, J Y ^a   Lu, S H ^a   Hsieh, C Y ^a   Pu, Y S ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Carcinoma, transitional cell; Cisplatin; Drug resistance, multiple; Glutathione; Glutathionetransferase

Indexed keywords

CISPLATIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; GENE CONTROL; IC 50; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GLUTATHIONE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; ISOENZYMES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0033794636     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cisplatin: Impact of a new anticancer agent on current therapeutic strategies
2. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response
3. Multidrug resistance-associated protein (MRP) gene expression in human, lung cancer
4. Function and regulation of the human multidrug resistance gene
5. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts
6. Multidrug resistance and its reversal
7. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype
8. Characterization of a newly established human bladder carcinoma cell line, NTUB1
9. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
10. Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands
11. Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines
12. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines
13. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells
14. Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum (II)
15. The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O6-alkylguanine-DNA-alkyltransferase of human turnout xenografts. EORTC SPG and PAMM Groups
16. Intracellular glutathione content of urothelial cancer in correlation to chemotherapy response
17. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs
18. Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas
19. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder
20. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells
21. Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs